Prof Research published a new Market report on Citicoline Market. It presents the largest 9 manufacturers in Citicoline Market. The report is a professional and in-depth study on the current state of the global Inks market with a focus on the Chinese market. The report provides key statistics on the market of Citicoline.  It is a valuable source of guidance and direction for companies and individuals interested in the Citicoline industry.

    KYOWA HAKKO is the largest manufacture of Citicoline around the world, it has a market share of 35.54% in value. KYOWA HAKKO BIO CO., LTD. is an international ingredients manufacturer whose primary goal is to provide health solutions that support optimal health for improved quality of life. Pioneers in the development and application of patented fermentation technology, Kyowa’s ingredients meet the most demanding quality assurance standards currently in place within the global dietary supplement, health food, cosmetic and pharmaceutical industries.

    AMRI is the second largest manufacture of Citicoline in the world, it has a market share of 14.76%% in value. AMRI (Albany Molecular Research Inc.) is a contract research and manufacturing organization that provides drug discovery, development, cGMP manufacturing and aseptic fill and finish to the pharmaceutical and biotechnology industries. Founded over 27 years ago, AMRI operates in the United States, Europe and Asia, with its headquarters located in Albany, New York.

    Tianma is the third largest manufacture of Citicoline in the world, it has a market share of 11.71% in value. Tianma Pharma Specialty Chemicals is one Subsidiary company of Tianma Pharma Group. Established in 1993, Tianma has become a major manufacturer of peptide related chemicals (including protected amino acids, among them Fmoc amino acids,Boc amino acids, CBZ amino acids and amino acids’ derivatives), peptide synthesis reagents and pharmaceutical intermediates.

    Xinxiang TUOXIN is the fouth largest manufacture of Citicoline in the world, it has a market share of 11.53% in value. Xinxiang Tuoxin Pharmaceutical Co., Ltd. (hereinafter referred to as the company) is a high-tech enterprise integrating the R & D, production and sales of chemical synthesis, biological fermentation nucleoside (acid) API and pharmaceutical intermediate. it has strong strength in the development and production of domestic nucleoside (acid) API and pharmaceutical intermediate products.